Methicillin-Resistant Staphylococcus aureus and Its Relationship to Antimicrobial Use: Possible Implications for Control

Infection Control and Hospital Epidemiology

Volumn 19, Issue 8, 1998, Pages 552-559

  Monnet, Dominique L ^a  

^a National Center for Hospital Hygiene Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; CLINICAL PRACTICE; CROSS INFECTION; DISEASE CARRIER; DISEASE TRANSMISSION; DOSE RESPONSE; DRUG EFFECT; EPIDEMIC; EUROPE; HOSPITAL; HUMAN; INFECTION CONTROL; PENICILLIN RESISTANCE; PHYSIOLOGY; PREVALENCE; REVIEW; STANDARD; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STATISTICS; UNITED STATES;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CROSS INFECTION; DISEASE OUTBREAKS; DISEASE RESERVOIRS; DOSE-RESPONSE RELATIONSHIP, DRUG; EUROPE; HOSPITALS; HUMANS; INFECTION CONTROL; METHICILLIN RESISTANCE; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TEXAS;

EID: 0032129890     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141779     Document Type: Article

References (100)

1. Ayliffe GAJ. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1997;24(suppl 1):S74-S79.
2. Voss A, Doebbeling BN. The worldwide prevalence of methicillin-resistant Staphylococcus aureus. International Journal of Antimicrobial Agents 1995;5:101-106.
3. Panlilio AL, Culver DH, Gaynes RP, Banerjee S, Henderson TS, Toison JS, et al. Methicillin-resistant Staphylococcus aureus in US hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992;13:582-586.
4. Struelens MJ, Ronveaux O, Jans B, Mertens R, the Groupement pour le Dépistage l'Etude et la Prévention des Infections Hospitalières. Methicillin-resistant Staphylococcus aureus epidemiology and control in Belgian hospitals, 1991 to 1995. Infect Control Hosp Epidemiol 1996;17:503-508.
5. Voss A, Milatovic D, Wallrauch-Schwartz C, Rosdahl VT, Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994;13:50-55.
6. Lugeon C, Blanc DS, Wenger A, Francioli R Molecular epidemiology of methicillin-resistant Staphylococcus aureus at a low-incidence hospital over a 4-year period. Infect Control Hosp Epidemiol 1995;16:260-267.
7. Stratton CW, IV, Ratner H, Johnston PE, Schaffner W. Focused microbiologic surveillance by specific hospital unit: practical application and clinical utility. Clin Ther 1993;15(suppl A):12-20.
8. Layton MC, Hierholzer WJ Jr, Patterson JE. The evolving epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital. Infect Control Hosp Epidemiol 1995;16:12-17.
9. Maguire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ. Emerging epidemic of community-acquired methicillin-resistant Staphylococcus aureus infection in the Northern Territory. Med J Aust 1996;164:721-723.
10. Moreno F, Crisp C, Jorgensen JH, Patterson JE. Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis 1995;21:1308-1312.
11. Saravolatz LD, Markowitz N, Arking L, Pohlod D, Fisher E. Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak. Ann Intern Med 1982;96:11-16.
12. Schito GC, Debbia EA, Pesce A. Susceptibility of respiratory strains of Staphylococcus aureus to fifteen antibiotics: results of a collaborative surveillance study (1992-1993). The Alexander Project Collaborative Group. J Antimicrob Chemother 1996;38(suppl A):97-106.
13. Wagenvoort JHT, Kepers-Rietrae M. Methicillin-resistant Staphylococcus aureus (MRSA) as a community strain. Eurosurveillance 1997;2:96-97.
14. Mayhall CG, Lamb VA, Gayle WE Jr, Haynes BW Jr. Enterobacter cloacae septicemia in a burn center: epidemiology and control of an outbreak. J Infect Dis 1979;139:166-171.
15. McGowan JE Jr, Tenover FC. Control of antimicrobial resistance in the health care system. Infect Dis Clin North Am 1997;11:297-311.
16. Pittet D, Caporalli M, Mourouga P, Alexiou A, Vaucher J, Hoffmeyer R Epidémie d'infections à MRSA liée à un manque de personnel. Schweiz Med Wochenschr 1996;126(suppl 74/II):129.
17. Hershow RC, Khayr WF, Smith NL. A comparison of clinical virulence of nosocomially acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus infections in a university hospital. Infect Control Hosp Epidemiol 1992;13:587-593.
18. Asensio A, Guerrero A, Quereda C, Lizán M, Martinez-Ferrer M. Colonization and infection with methicillin-resistant Staphylococcus aureus: associated factors and eradication. Infect Control Hosp Epidemiol 1996;17:20-28.
19. Humphreys H, Duckworth G. Methicillin-resistant Staphylococcus aureus (MRSA) - a re-appraisal of control measures in the light of changing circumstances. J Hosp Infect 1997;36:167-170.
20. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982;97:309-317.
21. Duckworth GJ. Diagnosis and management of methicillin resistant Staphylococcus aureus infection. BMJ 1993;307:1049-1052.
22. Emmerson M. Nosocomial staphylococcal outbreaks. Scand J Infect Dis 1994;93(suppl):47-54.
23. Ayliffe GAJ. Recommendations for the control of methicillin-resistant Staphylococcus aureus (MRSA). Geneva, Switzerland: Division of Emerging and other Communicable Diseases Surveillance and Control, World Health Organization: 1996.
24. Friis H, Vejlsgaard R. Antibiotika forbrug i Norden. Ugeskr Lœger 1986;148:2853-2855.
25. Frimodt-Meller N, Espersen F, Jacobsen B, Schlundt J, Meyling A, Wegener H. Problems with antibiotic resistance in Spain and their relation to antibiotic use in humans elsewhere. Clin Infect Dis 1997;25:939-941.
26. Janknegt R, Wijnands WJA, Caprasse M, Brandenburg W, Schuitenmaker MG, Stobberingh E. Antimicrobial drug use in hospitals in The Netherlands, Germany and Belgium. Eur J Clin Microbiol Infect Dis 1993;12:832-838.
27. Nordic Council on Medicines. Nordic Statistics on Medicines, 1990-1992. NLN publication no. 34. Uppsala, Sweden: Nordic Council on Medicine; 1993.
28. Boyce JM. Patterns of methicillin-resistant Staphylococcus aureus prevalence. Infect Control Hosp Epidemiol 1991;12:79-82.
29. Kolmos HJ. Hvidovre Hospital. Regler mod spredning af importerede multiresistente Staphylococcus aureus. Nord Med 1993;108:286-288.
30. Rosdahl VT, Westh H, Jensen K. Antibiotic susceptibility and phage-type pattern of Staphylococcus aureus strains isolated from patients in general practice compared to strains from hospitalized patients. Scand J Infect Dis 1990;22:315-320.
31. Rosdahl VT, Knudsen AM. The decline of methicillin resistance among Danish Staphylococcus aureus strains. Infect Control Hosp Epidemiol 1991;12:83-88.
32. Westh H, Jarløv JO, Kjersem H, Rosdahl VF. The disappearance of multiresistant Staphylococcus aureus in Denmark: changes in strains of the 83A complex between 1969 and 1989. Clin Infect Dis 1992;14:1186-1194.
33. Working Party of the Hospital Infection Society and British Society for Antimicrobial Chemotherapy. Revised guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect 1990;16:351-377.
34. CDSC. The spread of EMRSA-16. Commun Dis Rep CDR Weekly 1993;3:121.
35. Marples RR, Reith S. Methicillin-resistant Staphylococcus aureus in England and Wales. Comm Dis Report (PHLS, London) 1992;2(review 3):R25-R29.
36. Working Party of the British Society for Antimicrobial Chemotherapy. Hospital antibiotic control measures in the UK. J Antimicrob Chemother 1994;34:2142.
37. Moro ML, Jepsen OB, the EURO.NIS Study Group. Infection control practices in intensive care units of 14 European countries. Intensive Care Med 1996;22:872-879.
38. Kolmos HJJ. Restriktiv antibiotikapolitik forebygger hospitalinfektioner. Ugeskr Lœger 1994;156:2053.
39. McGowan JE Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983;5:1033-1048.
40. McGowan JE Jr. Is antimicrobial resistance in hospital microorganisms related to antibiotic use? Bull N Y Acad Med 1987;63:253-268.
41. Archibald L, Phillips L, Monnet D, McGowan JE Jr, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997;24:211-215.
42. Loulergue J, Audurier A, DeLarbre JM, De Gialluly C. Changes in microbial ecology and use of cloxacillin. J Hosp Infect 1994;27:275-283.
43. Crossley K, Loesch D, Landesman B, Mead K, Chern M, Strate R. An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides: I, clinical studies. J Infect Dis 1979;139:273-279.
44. Boyce JM, Landry M, Deetz TR, DuPont HL. Epidemiologic studies of an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections. Infect Control 1981;2:110-116.
45. French GL, Cheng AFB, Ling JML, Mo P, Donnan S. Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence. J Hosp Infect 1990;15:117-125.
46. Law MR, Gill ON. Hospital-acquired infection with methicillin-resistant and methicillin-sensitive staphylococci. Epidemiol Infect 1988;101:623-629.
47. Peacock JE, Marsik FJ, Wenzel RP. Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Ann Intern Med 1980;93:526-532.
48. Pujol M, Pena C, Pallares R, Ayats J, Ariza J, Gudiol F. Risk factors for nosoeomial bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1994;13:96-102.
49. Rello J, Torres A, Ricart M, Valles J, Gonzalez J, Artigas A, et al. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994;150(6, part 1):1545-1549.
50. Ward TT, Winn RE, Harstein AI, Sewell DL. Observations relating to an inter-hospital outbreak of methicillin-resistant Staphylococcus aureus: role of antimicrobial therapy in infection control. Infect Control 1981;2:453-459.
51. Crowcroft N, Maguire H, Fleming M, Peacock J, Thomas J. Methicillin-resistant Staphylococcus aureus: investigation of a hospital outbreak using a case-control study. J Hosp Infect 1996;34:301-309.
52. Grundmann H. Methicillin-Resistant Staphylococcus aureus in a Teaching Hospital: Investigation of Nosoeomial Transmission Using a Matched Case-Control Study. London, England: London School of Hygiene and Tropical Medicine; 1997. Dissertation.
53. Monnet DL, Archibald L, Tenover F, McGowan JE Jr, Gaynes R. Project ICARE (Intensive Care Antimicrobial Resistance Epidemiology) : a practical approach for surveillance of antimicrobial resistance and usage in hospitals. Clin Microbiol Infect 1997;3(suppl 2):71. Abstract.
54. The CPL Trends Database. Buffalo, NY: Millard Fillmore Hospital; 1998. Available from: URL: http://resistanceweb.mfhs.edu.
55. Crowcroft NS, Ronveaux O, Monnet DL, Mertens R. Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals. Presented at the Eighth Annual Meeting of The Society for Healthcare Epidemiology of America; April, 1998; Orlando, FL. Abstract 29.
56. Jevons MP. "Celbenin"-resistant staphylococci. BMJ 1961;1:124-125.
57. Ayliffe GAJ, Lilly HA, Lowbury EJL Decline of the hospital Staphylococcus? Incidence of multiresistant Staph aureus in three Birmingham hospitals. Lancet 1979;1:538-541.
58. Shanson DC, Kensit JG, Duke R. Outbreak of hospital infection with a strain of Staphylococcus aureus resistant to gentamicin and methicillin. Lancet 1976;2:1347-1348.
59. Vandenbroucke-Grauls CMJE. The threat of multiresistant microorganisms. Eur J Clin Microbiol Infect Dis 1993;12(suppl 1):27-30.
60. Pallares R, Dick R, Wenzel RP, Adams JR, Nettleman MD. Trends in antimicrobial utilization at a tertiary teaching hospital during a 15-year period (1978-1992). Infect Control Hosp Epidemiol 1993;14:376-382.
61. Høiby N. Epidemiologic aspects on antibiotic resistance. Microb Drug Res 1995;1:137-142.
62. Blumberg HM, Rimland D, Carroll DJ, Terry P, Wachsmuth IK. Rapid development of ciprofloxacin resistance in methicillin-susceptible and resistant Staphylococcus aureus. J Infect Dis 1991;163:1279-1285.
63. Chang S-C, Hsieh W-C, Luh K-T. Fluoroquinolone resistance among methicillin-resistant staphylococci after usage of fluoroquinolones other than ciprofloxacin in Taiwan. Diagn Microbiol Infect Dis 1994;19:143-147.
64. Fass RJ, Barnishan J, Ayers LW. Emergence of bacterial resistance to imipenem and ciprofloxacin in a university hospital. J Antimicrob Chemother 1995;36:343-353.
65. Goldstein FW, Acar JF. Epidemiology of quinolone resistance: Europe and North and South America. Drugs 1995;49(suppl 2):36-42.
66. Raviglione MC, Boyle JF, Mariuz P, Pablos-Mendez A, Cortes H, Merlo A. Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute care hospital. Antimicrob Agents Chemother 1990;34:2050-2054.
67. Sanders CC, Sanders WE Jr, Thomson KS. Fluoroquinolone resistance in staphylococci: new challenges. Eur J Clin Microbiol Infect Dis 1995;14(suppl 1):6-11.
68. Coronado VG, Edwards JR, Culver DH, Gaynes RP, the National Nosocomial Infections Surveillance (NNIS) System. Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol 1995;16:71-75.
69. Lew DP, Garbino J, Gerber AU, Sudre P, the Swiss Committee of Anti-Infective Agents. Use of antimicrobials in Swiss hospitals. Drugs 1996;52(suppl 2):88-91.
70. Rosendal K, Jessen O, Bentzon VTW, Bülow P. Antibiotic policy and spread of Staphylococcus aureus strains in Danish hospitals, 1969-1974. Acta Pathol Microbiol Scand 1977;55(sect B):143-152.
71. Nordic Council on Medicines. Nordic Statistics on Medicines, 1978-1980. NLN publication no. 8. Uppsala: Nordic Council on Medicines; 1982.
72. Bager F, ed. Consumption of Antimicrobial Agents and Occurence of Antimicrobial Resistance in Bacteria From Food, Animals and Humans in Denmark. Copenhagen, Denmark: Danish Integrated Antimicrobial Resistance Monitoring and Research Programme; 1997.
73. Schentag JJ, Hyatt JM, Gutfeld MB, Cumbo TJ. Improving antibiotic usage in health care systems: the role of clinical pharmacy in an interdisciplinary process. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. 1995; San Francisco, CA. American Society for Microbiology; 1995:353. Abstract.
74. Crossley K, Landesman B, Zaske D. An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides, II: epidemiologic studies. J Infect Dis 1979;139:280-287.
75. Frank MO, Batteiger BE, Sorensen SJ, Hartstein AI, Carr JA, McComb JS, et al. Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program. Clinical Performance and Quality Health Care 1997;5:180-188.
76. Harstein AI, LeMonte AM, Iwamoto PKL. DNA typing and control of methicillin-resistant Staphylococcus aureus at two affiliated hospitals. Infect Control Hosp Epidemiol 1997;18:42-48.
77. Finland M. Emergence of antibiotic-resistant bacteria. N Engl J Med 1955;253:909-922,969-979,1019-1028.
78. Knight V, Holzer AR. Studies on staphylococci from hospital patients, I: predominance of strains of group III phage patterns which are resistant to multiple antibiotics. J Clin Invest 1954;33:1190-1198.
79. Knight V, White AC. Drug resistant staphylococci, part I: their distribution in hospital patients. South Med J 1956;49:1173-1187.
80. Lepper MH, Dowling HF, Jackson GG, Hirsch MM. Epidemiology of penicillin-aureomycin-resistant staphylococci in a hospital population. Arch Intern Med 1953;92:40-50.
81. Berntsen CA, McDermott W. Increased transmissibility of staphylococci to patients receiving an antimicrobial drug. N Engl J Med 1960;262:637-642.
82. Haiby N, Jarløv JO, Kemp M, Tvede M, Bangsborg JM, Kjerulf A, et al. Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis. Lancet 1997;349:167-169.
83. Pujol M, Peña C, Pallares R, Ariza J, Ayats J, Dominguez MA, et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996;100:509-516.
84. Rimland D, Roberson B. Gastrointestinal carriage of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1986;24:137-138.
85. Saunders GL, Hammond JM, Potgieter PD, Plumb HA, Forder AA. Microbiological surveillance during selective decontamination of the digestive tract (SDD). [Erratum: J Antimicrob Chemother 1995;35:561]. J Antimicrob Chemother 1995;34:529-544.
86. Tetteroo GW, Wagenvoort JH, Bruining HA. Bacteriology of selective decontamination: efficacy and rebound colonization. J Antimicrob Chemother 1994;34:139-148.
87. Kaufhold A, Behrendt W, Kräuss T, van Saene H. Selective decontamination of the digestive tract and methicillin-resistant Staphylococcus aureus. Lancet 1992;339:1411-1412.
88. Archer GL, Armstrong BC. Alteration of staphylococcal flora in cardiac surgery patients receiving antibiotic prophylaxis. J Infect Dis 1983;147:642-649.
89. Beard-Pegler MA, Stubbs E, Vickery AM. Observations on the resistance to drying of staphylococcal strains. J Med Microbiol 1988;26:251-255.
90. Frénay HME, Theelen JPG, Schouls LM, Vandenbroucke-Grauls CMJE, Verhoef J, van Leeuwen WJ, et al. Discrimination of epidemic and non epidemic methicillin-resistant Staphylococcus aureus strains on the basis of protein A polymorphism. J Clin Microbiol 1994;32:846-847.
91. Roberts JIS, Gaston MA Protein A and coagulase expression in epidemic and non-epidemic Staphylococcus aureus. J Clin Pathol 1987;40:837-840.
92. van Wamel WJB, Huit AC, Wadström T, van Dijk H, Verhoef J, Vandenbroucke-Grauls CMJE. Phenotypic characterization of epidemic versus sporadic strains of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1995;33:1769-1774.
93. Bisognano C, Vaudaux PE, Lew DP, Ng EYW, Hooper DC. Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother 1997;41:906-913.
94. Jepsen OB. The demise of the 'old' methicillin-resistant Staphylococcus aureus. J Hosp Infect 1986;7(suppl A):13-17.
95. Witte W, Braulke C, Heuck D, Cuny C. Analysis of nosocomial out-breaks with multiply and methicillin-resistant Staphylococcus aureus (MRSA) in Germany: implications for hospital hygiene. Infection 1994;2(suppl 2):S128-S134.
96. van Eldere J, Borremans A, Schuermans A, Thelissen MJ. Methicillin resistant Staphylococcus aureus in the university hospitals Leuven. Study of their origin and spread and of the effect of measures to reduce their presence. Bulletin d'Information Hygiène Hospitalière (Belgium) 1995;17:46-47.
97. Aubry-Damon H, Legrand P, Brun-Buisson C, Astier A, Soussy C-J, Leclercq R, Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus: roles of an infection control program and changes in aminoglycoside use. Clin Infect Dis 1997;25:647-653.
98. Lemaître N, Sougakoff W, Masmoudi A, Fievet M-H, Bismuth R, Jarlier V. Characterization of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus involved in nosocomial spread. J Clin Microbiol 1998;36:81-85.
99. Harstein AI. Improved understanding and control of nosocomial methicillin-resistant Staphylococcus aureus: are we overdoing it? Infect Control Hosp Epidemiol 1995;16:257-259.
100. Dunkle LM, Naqvi SH, McCallum R, Lofgren JP Eradication of epidemic methicillin-gentamicin-resistant Staphylococcus aureus in an intensive care nursery. Am J Med 1981;70:455-458.